These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 3288296)

  • 1. Genetically engineered antibody molecules: new tools for cancer therapy.
    Morrison SL; Wims LA; Oi VT
    Cancer Invest; 1988; 6(2):185-92. PubMed ID: 3288296
    [No Abstract]   [Full Text] [Related]  

  • 2. Production and characterization of genetically engineered antibody molecules.
    Morrison SL; Canfield S; Porter S; Tan LK; Tao MH; Wims LA
    Clin Chem; 1988 Sep; 34(9):1668-75. PubMed ID: 3138036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetically engineered (chimeric) antibodies.
    Morrison SL
    Hosp Pract (Off Ed); 1989 Oct; 24(10):65-9, 72-4, 77-80. PubMed ID: 2551912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advances in monoclonal antibody technology: genetic engineering of mice, cells, and immunoglobulins.
    Peterson NC
    ILAR J; 2005; 46(3):314-9. PubMed ID: 15953839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Of mice and men: hybridoma and recombinant antibodies.
    Little M; Kipriyanov SM; Le Gall F; Moldenhauer G
    Immunol Today; 2000 Aug; 21(8):364-70. PubMed ID: 10916138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tailor-made monoclonal antibodies.
    DePinho RA; Feldman LB; Scharff MD
    Ann Intern Med; 1986 Feb; 104(2):225-33. PubMed ID: 3080934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Production of a diverse repertoire of human antibodies in genetically engineered mice.
    Ishida I; Yoshida H; Tomizuka K
    Microbiol Immunol; 1998; 42(3):143-50. PubMed ID: 9570278
    [No Abstract]   [Full Text] [Related]  

  • 8. Genetically engineered antibody molecules.
    Morrison SL; Oi VT
    Adv Immunol; 1989; 44():65-92. PubMed ID: 2646862
    [No Abstract]   [Full Text] [Related]  

  • 9. Man-made antibodies.
    Winter G; Milstein C
    Nature; 1991 Jan; 349(6307):293-9. PubMed ID: 1987490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetically engineered antibody molecules and their application.
    Morrison SL; Wims L; Wallick S; Tan L; Oi VT
    Ann N Y Acad Sci; 1987; 507():187-98. PubMed ID: 3327412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Engineering mouse monoclonal antibodies for cancer immunotherapy.
    Orlandi R
    Year Immunol; 1993; 7():69-73. PubMed ID: 8372514
    [No Abstract]   [Full Text] [Related]  

  • 12. Human and murine immunoglobulin expression vector cassettes.
    McLean GR; Nakouzi A; Casadevall A; Green NS
    Mol Immunol; 2000 Oct; 37(14):837-45. PubMed ID: 11257305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vl-linker-Vh orientation-dependent expression of single chain Fv-containing an engineered disulfide-stabilized bond in the framework regions.
    Luo D; Mah N; Krantz M; Wilde K; Wishart D; Zhang Y; Jacobs F; Martin L
    J Biochem; 1995 Oct; 118(4):825-31. PubMed ID: 8576099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A genetically engineered murine/human chimeric antibody retains specificity for human tumor-associated antigen.
    Sahagan BG; Dorai H; Saltzgaber-Muller J; Toneguzzo F; Guindon CA; Lilly SP; McDonald KW; Morrissey DV; Stone BA; Davis GL
    J Immunol; 1986 Aug; 137(3):1066-74. PubMed ID: 3088107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Antibody engineering and gene therapy in cancer].
    Hinoda Y; Imai K
    Nihon Rinsho Meneki Gakkai Kaishi; 1996 Oct; 19(5):453-9. PubMed ID: 8983663
    [No Abstract]   [Full Text] [Related]  

  • 16. Antibody engineering via genetic engineering of the mouse: XenoMouse strains are a vehicle for the facile generation of therapeutic human monoclonal antibodies.
    Green LL
    J Immunol Methods; 1999 Dec; 231(1-2):11-23. PubMed ID: 10648924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A method for rapid, ligation-independent reformatting of recombinant monoclonal antibodies.
    Jones ML; Seldon T; Smede M; Linville A; Chin DY; Barnard R; Mahler SM; Munster D; Hart D; Gray PP; Munro TP
    J Immunol Methods; 2010 Mar; 354(1-2):85-90. PubMed ID: 20153332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential of genetically engineered anti-ganglioside GD2 antibodies for cancer immunotherapy.
    Reisfeld RA; Mueller BM; Handgretinger R; Yu AL; Gillies SD
    Prog Brain Res; 1994; 101():201-12. PubMed ID: 8029452
    [No Abstract]   [Full Text] [Related]  

  • 19. Clonal analysis of a human antibody response. Quantitation of precursors of antibody-producing cells and generation and characterization of monoclonal IgM, IgG, and IgA to rabies virus.
    Ueki Y; Goldfarb IS; Harindranath N; Gore M; Koprowski H; Notkins AL; Casali P
    J Exp Med; 1990 Jan; 171(1):19-34. PubMed ID: 2153188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Production of novel immunoglobulin molecules by gene transfection.
    Morrison SL; Wims LA; Kobrin B; Oi VT
    Mt Sinai J Med; 1986 Mar; 53(3):175-80. PubMed ID: 3084959
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.